Advertisement
Bluebird Bio Q3 Loss Narrows, Tops Estimates; Revenues Miss Estimates
(RTTNews) - Bluebird Bio, Inc. (BLUE) reported Tuesday a net loss for the third quarter of $71.73 million or $0.66 per share, narrower than $76.52 million or $0.94 per share in the prior-year quarter.
Total revenues for the quarter soared to $12.39 million from $0.01 million in the same quarter last year, primarily due to SKYSONA and ZYNTEGLO product revenue. On average, analysts polled by Thomson Reuters expected the company to report a loss of $0.67 per share on revenues of $13.41 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
Bluebird Bio Says FDA Accepts BLA For Lovotibeglogene Autotemcel For Priority Review
bluebird bio, Inc. (BLUE) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for lovotibeglogene autotemcel (lovo-cel) for priority review. The agency has set a Prescription Drug User Fee Act (PDUFA) goal date of December 20, 2023.
RTTNews
|
796 ngày trước
U.S. Dollar Climbs Against Majors
The U.S. dollar strengthened against its major counterparts in the New York session on Monday.
RTTNews
|
43 phút trước
Swiss Market Ends Moderately Lower
After a weak start and a subsequent long spell in negative territory, the Switzerland market briefly moved slightly above the flat line in late afternoon trades on Monday, but quickly tumbled again to eventually settle on a weak note.
RTTNews
|
3h 29phút trước
European Markets Close Weak After Cautious Session
European stocks closed on a weak note on Monday after a cautious session as investors awaited key inflation data from major economies in the region, and looked for more details about U.S. - EU trade deal.
RTTNews
|
3h 49phút trước
Canadian Market Down More Than 0.5% On Profit Taking
After opening slightly down, the Canadian market slipped deeper into the red on Monday, weighed down by losses in healthcare, consumer staples, utilities and materials sectors.
RTTNews
|
4h 29phút trước
U.S. New Home Sales Pull Back From Upwardly Revised Level In July
New home sales in the U.S. decreased from an upwardly revised level in the month of July, according to a report released by the Commerce Department on Monday. The Commerce Department said new home sales fell by 0.6 percent to an annual rate of 652,000 in July after surging by 4.1 percent to an upwardly revised rate of 656,000 in June.
RTTNews
|
6h 13phút trước
Bay Street May Open On Weak Note
Canadian shares may open on a weak note Monday morning, tracking lower metal prices and European stocks. However, energy stocks may find support on higher oil prices, and help limit market's downside.
RTTNews
|
8h 55phút trước
Dollar Extends Losses Amidst Powell's Dovish Surprise
A markedly dovish tone in Fed Chair Jerome Powell's speech at the Jackson Hole symposium on Friday weakened the Dollar, resulting in further losses for the currency during the week ended August 22.
RTTNews
|
9h 40phút trước
